Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains

@article{Ngamukote2007DevelopmentalCO,
  title={Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains},
  author={Sathaporn Ngamukote and Makoto Yanagisawa and Toshio Ariga and Susumu Ando and Robert K Yu},
  journal={Journal of Neurochemistry},
  year={2007},
  volume={103}
}
Glycosphingolipids (GSLs) and their sialic acid‐containing derivatives, gangliosides, are important cellular components and are abundant in the nervous system. They are known to undergo dramatic changes during brain development. However, knowledge on the mechanisms underlying their qualitative and qualitative changes is still fragmentary. In this investigation, we have provided a detailed study on the developmental changes of the expression patterns of GSLs, GM3, GM1, GD3, GD1a, GD2, GD1b, GT1b… 
Epigenetic regulation of ganglioside expression in neural stem cells and neuronal cells
TLDR
Ep epigenetic regulation of ganglioside synthase genes in neural development and neuronal differentiation of NSCs is introduced.
Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation
TLDR
Insight is provided into the unique stage-specific transition and mechanism for alterations of GSL core structures during hESC differentiation and unique glycan structures uncovered by MS analyses may serve as surface markers for further delineation of hESCs and help identify of their functional roles not only in h ESCs but also in cancers.
Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis
TLDR
The data suggest that the complex a-series gangliosides are reduced in Cln3Δex7/8 mouse cerebellar precursor cells due to impaired transcription of the genes responsible for their synthesis, including GM3, GM2, GM1a and GD1a.
Subregional brain distribution of simple and complex glycosphingolipids in the mucopolysaccharidosis type I (Hurler syndrome) mouse: impact of diet
TLDR
Dietary linoleic acid supplementation significantly reduced GM2 and GM3, and furthermore, improved exploratory behaviour as assessed by the open field test, highlighting the possibility of further exploring dietary intervention as a therapeutic consideration.
GM1 Ganglioside is Involved in Epigenetic Activation Loci of Neuronal Cells
TLDR
Evidence supporting the concept that nuclear GM1 is associated with gene regulation in neuronal cells is presented, and it is demonstrated for the first time that GM1 interacts with chromatin via acetylated histones at the nuclear periphery of neuronal cells.
Human Embryonic Stem Cell Differentiation: Role of Glycosphingolipid Structure
Glycosphingolipids (GSLs) are ubiquitous components of cell membranes that can act as mediators of cell adhesion and signal transduction and possibly be used as cell type-specific markers. A
Alterations of Glycosphingolipids in Embryonic Stem Cell Differentiation and Development of Glycan-Targeting Cancer Immunotherapy
TLDR
This work employed matrix-assisted laser desorption–ionization mass spectrometry and tandem MS/MS analyses to systematically delineate changes in GSLs during differentiation of human embryonic stem and induced pluripotent stem cells into various derivatives.
Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic Gaucher disease
TLDR
This is the first detailed analysis of glycosphingolipids in various brain regions in a large animal model of neuronal disease, which permits the mechanistic investigation of lipid deregulation and their contribution to neurodegenerative process.
Alterations of membrane lipids and in gene expression of ganglioside metabolism in different brain structures in a mouse model of mucopolysaccharidosis type I (MPS I).
TLDR
Evaluated levels and distribution of gangliosides and cholesterol in different brain regions in a model using IDUA knockout (KO) mice suggest that the observedganglioside changes result from a combined effect of GAGs on gangliosiside biosynthesis and degradation.
Developmental stage-dependent expression of an alpha2,8-trisialic acid unit on glycoproteins in mouse brain.
The monoclonal antibody mAb.A2B5 is a marker for the detection of oligodendrocyte progenitor cells that differentiate into type-2 astrocytes and oligodendrocytes. It is also a useful antibody for
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 104 REFERENCES
Developmental Changes in Ganglioside Composition and Synthesis in Embryonic Rat Brain
TLDR
Changes in ganglioside composition and enzymatic activities indicate that during development there is a shift from synthesis of the simplest ganglioides of the “a” and “b” pathways to synthesis of one of the more complex gangsliosides.
Mouse β 1,3‐galactosyltransferase (GA1/GM1/GD1b synthase): Protein characterization, tissue expression, and developmental regulation in neural retina
TLDR
The isolation and characterization of a mouse Gal‐T2 cDNA that drives the synthesis of an epitope‐tagged protein of molecular mass 43 kDa, which was enzymatically active and localized to the Golgi complex in transfected cell lines is described.
Ganglioside Composition of Normal and Mutant Mouse Embryos
TLDR
The composition and distribution of gangliosides in tw1/tw1 mutant mouse embryos at E‐12 suggest that b pathway gang liosides accumulate in differentiating neural cells and that the deficiency of these gangliosisides in the tw1 /tw1 mutants is closely associated with failed neural differentiation.
Ganglioside GM1 elevation in DBA/2 mouse embryos.
TLDR
The results suggest that the elevated GM1 in D2 embryos may result from a reduced activity of GM1 beta-galactosidase, and that the whole embryo ganglioside sialic concentration was significantly lower in D 2 embryos than in B6 or C3H embryos.
Neutral monoglycosylceramides in rat brain: occurrence, molecular expression and developmental variation.
TLDR
A reduction in brain FMC concentrations along with GalCer in murine genetic dysmyelinating disorders (jimpy and quaking) further supports the conclusion that they are myelin constituents.
Stage-specific expression of fuco-neolacto- (Lewis X) and ganglio-series neutral glycosphingolipids during brain development: characterization of Lewis X and related glycosphingolipids in bovine, human and rat brain
We have purified and characterized a bovine brain pentaglycosylceramide as Lewis X and identified it in human and rat brain using anti-Lewis X (anti-SSEA 1) monoclonal antibody. Neutral
beta-1,4-N-Acetylgalactosaminyltransferase involved in ganglioside synthesis: cDNA sequence, expression, and chromosome mapping of the mouse gene.
TLDR
The mouse GalNAc-T transcript was most abundantly expressed in brain, liver, lung, spleen, and testis among the eight adult tissues examined, and relatively high levels of expression were seen early in mouse development compared to later times.
Heterogeneity in the Expression Pattern of Two Ganglioside Synthase Genes During Mouse Brain Development
TLDR
The findings suggest that various expression patterns of the two genes reflect differences in the course of the development of individual sites, and also different ganglioside components are required in individual portions of the brain for development and maintenance of the function.
Developmental changes in the expression of glycogenes and the content of N-glycans in the mouse cerebral cortex.
TLDR
It is demonstrated that the content of N-linked oligosaccharides dramatically changed during the course of brain development, and the amount of sugar chains with an outer fucose residue, containing LewisX-BA-2, correlated well with the expression of fusocyltransferase IX mRNA.
Development regulation of ganglioside metabolism.
  • R. K. Yu
  • Biology, Medicine
    Progress in brain research
  • 1994
TLDR
Evidence from analysis of the gene for this enzyme revealed binding sequences for a number of liver restricted transcription factors such as hepatocyte nuclear factor l a, liver specific factors D-binding protein (DBP), and liver enriched transcription activator protein (LAP), as well as the more general transcription factors AP-1 and AP-2.
...
1
2
3
4
5
...